We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
251
O'Reilly Automotive
ORLY
$76.3B
$72.1M 0.07%
1,711,320
+349,725
+26% +$15M
SPAB icon
252
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.94B
$71M 0.07%
2,693,096
+448,538
+20% +$12M
DEO icon
253
Diageo
DEO
$53.6B
$70.9M 0.07%
407,417
-21,526
-5% -$4.09M
MNST icon
254
Monster Beverage
MNST
$88.5B
$70.8M 0.07%
1,527,600
-28,150
-2% -$1.22M
ICSH icon
255
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.4B
$69.5M 0.07%
1,389,742
+160,249
+13% +$8.03M
SRLN icon
256
State Street Blackstone Senior Loan ETF
SRLN
$5.36B
$69.5M 0.07%
1,668,731
+505,116
+43% +$22M
NGG icon
257
National Grid
NGG
$81.3B
$68.6M 0.07%
1,143,578
-12,239
-1% -$810K
TIP icon
258
iShares TIPS Bond ETF
TIP
$14.7B
$68.5M 0.07%
601,467
+15,120
+3% +$1.79M
FCX icon
259
Freeport-McMoran
FCX
$97.5B
$67.9M 0.07%
2,320,530
+261,073
+13% +$10.4M
BSX icon
260
Boston Scientific
BSX
$71.5B
$67.5M 0.07%
1,811,374
-59,914
-3% -$2.44M
AMAT icon
261
Applied Materials
AMAT
$428B
$67.3M 0.07%
739,449
-179,018
-19% -$19.6M
VLO icon
262
Valero Energy
VLO
$85.9B
$67.2M 0.07%
632,431
-107,951
-15% -$12.8M
AXP icon
263
American Express
AXP
$230B
$67M 0.07%
483,158
+1,458
+0.3% +$241K
LQD icon
264
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$66.9M 0.07%
607,853
-117,024
-16% -$13.2M
IGIB icon
265
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$66.7M 0.07%
1,306,325
+48,952
+4% +$2.55M
BKNG icon
266
Booking.com
BKNG
$161B
$66M 0.06%
943,725
-374,375
-28% -$31.9M
GSK icon
267
GSK
GSK
$106B
$65.4M 0.06%
1,201,323
+76,539
+7% +$4.23M
AES icon
268
AES
AES
$10.5B
$65M 0.06%
3,095,313
-78,689
-2% -$1.72M
PPG icon
269
PPG Industries
PPG
$26.6B
$64.8M 0.06%
566,741
+23,954
+4% +$2.99M
NVS icon
270
Novartis
NVS
$297B
$64.5M 0.06%
762,796
-128,085
-14% -$11.2M
CARR icon
271
Carrier Global
CARR
$52.8B
$64.3M 0.06%
1,804,418
-90,431
-5% -$3.55M
DOW icon
272
Dow Inc
DOW
$21.2B
$64.1M 0.06%
1,242,469
+82,871
+7% +$5.31M
IUSB icon
273
iShares Core Universal USD Bond ETF
IUSB
$43.3B
$63.3M 0.06%
1,351,894
-73,553
-5% -$3.49M
DIA icon
274
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.5B
$62.8M 0.06%
204,048
-2,432
-1% -$795K
GLW icon
275
Corning
GLW
$143B
$61.8M 0.06%
1,962,020
-28,592
-1% -$985K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.